EN HU

Takács Barbara

Takács Barbara

Publication list

Uploaded publications:
14
Publications in DEA:
14
OA:
14
Date range:
2021-2024
2024
1.
Piros, Z., Kispál, K., Szekeres, R., Takács, B., Kiss, R., Szabó, A. M., Ujvárosy, D., Szabó, Z., Szilvássy, Z., Gesztelyi, R., Juhász, B.: Alarming Signal from the Ear: Tinnitus, a Possible Epiphenomenon of Silent Hyperlipidaemia.
Biomedicines. 12 (12), 1-14, (article identifier: 2837), 2024.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
Q1 Medicine (miscellaneous) (2023)
2.
Szilágyi, A., Takács, B., Szekeres, R., Tarjányi, V., Nagy, D., Priksz, D., Bombicz, M., Kiss, R., Szabó, A. M., Lehoczki, A., Gesztelyi, R., Juhász, B., Szilvássy, Z., Varga, B.: Effects of voluntary and forced physical exercise on the retinal health of aging Wistar rats.
GeroScience. 46 (5), 4707-4728, 2024.
Journal metrics:
Q1 Aging (2023)
Q1 Cardiology and Cardiovascular Medicine (2023)
D1 Complementary and Alternative Medicine (2023)
Q1 Geriatrics and Gerontology (2023)
D1 Veterinary (miscellaneous) (2023)
3.
Takács, B., Szilágyi, A., Priksz, D., Bombicz, M., Szabó, A. M., Pelles-Taskó, B., Rusznyák, Á., Haimhoffer, Á., Gesztelyi, R., Szilvássy, Z., Juhász, B., Varga, B.: Electroretinographical Analysis of the Effect of BGP-15 in Eyedrops for Compensating Global Ischemia-Reperfusion in the Eyes of Sprague Dawley Rats.
Biomedicines. 12 (3), 1-16, (article identifier: 637), 2024.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
Q1 Medicine (miscellaneous) (2023)
4.
Pelles-Taskó, B., Szekeres, R., Takács, B., Szilágyi, A., Ujvárosy, D., Bombicz, M., Priksz, D., Varga, B., Gesztelyi, R., Szabó, Z., Szilvássy, Z., Juhász, B.: From Nature to Treatment: The Impact of Pterostilbene on Mitigating Retinal Ischemia-Reperfusion Damage by Reducing Oxidative Stress, Inflammation, and Apoptosis.
Life (Basel). 14 (9), 1-13, (article identifier: 1148), 2024.
Journal metrics:
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2023)
Q2 Ecology, Evolution, Behavior and Systematics (2023)
Q1 Paleontology (2023)
Q2 Space and Planetary Science (2023)
5.
Óvári, I., Viczján, G., Erdei, T. D., Takács, B., Tarjányi, V., Zsuga, J., Szűcs, M., Szilvássy, Z., Juhász, B., Gesztelyi, R.: The influence of the way of regression on the results obtained by the receptorial responsiveness method (RRM), a procedure to estimate a change in the concentration of a pharmacological agonist near the receptor.
Front. Pharmacol. 15, 1-18, (article identifier: 1375955), 2024.
Journal metrics:
Q1 Pharmacology (2023)
Q1 Pharmacology (medical) (2023)
2023
6.
Bernát, B., Erdélyi, R., Fazekas, L., Garami, G., Szekeres, R., Takács, B., Bombicz, M., Varga, B., Sárkány, F., Ráduly, A. P., Romanescu, D. D., Papp, Z., Tóth, A., Szilvássy, Z., Juhász, B., Priksz, D.: Drug Candidate BGP-15 Prevents Isoproterenol-Induced Arrhythmias and Alters Heart Rate Variability (HRV) in Telemetry-Implanted Rats.
Pharmaceuticals (Basel). 16 (3), 1-22, (article identifier: 359), 2023.
Journal metrics:
Q2 Drug Discovery
Q2 Molecular Medicine
Q1 Pharmaceutical Science
7.
Blága, Z., Czine, P., Takács, B., Szilágyi, A., Szekeres, R., Wachal, Z., Hegedűs, C., Buchholcz, G., Varga, B., Priksz, D., Bombicz, M., Szabó, A. M., Kiss, R., Gesztelyi, R., Romanescu, D. D., Szabó, Z., Szűcs, M., Balogh, P., Szilvássy, Z., Juhász, B.: Examination of Preferences for COVID-19 Vaccines in Hungary Based on Their Properties: Examining the Impact of Pandemic Awareness with a Hybrid Choice Approach.
Int. J. Environ. Res. Public Health. 20 (2), 1-16, (article identifier: 1270), 2023.
Journal metrics:
Q2 Health, Toxicology and Mutagenesis
Q2 Pollution
Q2 Public Health, Environmental and Occupational Health
8.
Szekeres, R., Priksz, D., Kiss, R., Romanescu, D. D., Bombicz, M., Varga, B., Gesztelyi, R., Szilágyi, A., Takács, B., Tarjányi, V., Pelles-Taskó, B., Forgács, I. N., Gálné Remenyik, J., Szilvássy, Z., Juhász, B.: Therapeutic Aspects of Prunus cerasus Extract in a Rabbit Model of Atherosclerosis-Associated Diastolic Dysfunction.
Int. J. Mol. Sci. 24 (17), 1-19, (article identifier: 13253), 2023.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
2022
9.
Kozma, M., Bombicz, M., Varga, B., Priksz, D., Gesztelyi, R., Tarjányi, V., Kiss, R., Szekeres, R., Takács, B., Ménes, Á., Balla, J., Balla, G., Szilvássy, J., Szilvássy, Z., Juhász, B.: Cardioprotective Role of BGP-15 in Ageing Zucker Diabetic Fatty Rat (ZDF) Model: extended Mitochondrial Longevity.
Pharmaceutics. 14 (2), 1-16, (article identifier: 226), 2022.
Journal metrics:
Q1 Pharmaceutical Science
10.
Wachal, Z., Szilágyi, A., Takács, B., Szabó, A. M., Priksz, D., Bombicz, M., Szilvássy, J., Juhász, B., Szilvássy, Z., Varga, B.: Corrigendum: Improved survival and retinal function of aging ZDF rats in long-term, uncontrolled diabetes by BGP-15 treatment.
Front. Pharmacol. 13, 1-1, (article identifier: 1034389), 2022.
11.
Viczján, G., Szilágyi, A., Takács, B., Óvári, I., Szekeres, R., Tarjányi, V., Erdei, T. D., Teleki, V., Zsuga, J., Szilvássy, Z., Juhász, B., Varga, B., Gesztelyi, R.: The effect of a long-term treatment with cannabidiol-rich hemp extract oil on the adenosinergic system of the Zucker Diabetic Fatty (ZDF) rat atrium.
Front. Pharmacol. 13, 1-12, 2022.
Journal metrics:
Q1 Pharmacology
Q1 Pharmacology (medical)
12.
Szilágyi, A., Takács, B., Szekeres, R., Tarjányi, V., Bombicz, M., Priksz, D., Kovács, A. I., Juhász, B., Frecska, E., Szilvássy, Z., Varga, B.: Therapeutic Properties of Ayahuasca Components in Ischemia/Reperfusion Injury of the Eye.
Biomedicines. 10 (5), 1-19, 2022.
Journal metrics:
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1 Medicine (miscellaneous)
2021
13.
Viczján, G., Erdei, T. D., Óvári, I., Lampé, N., Szekeres, R., Bombicz, M., Takács, B., Szilágyi, A., Zsuga, J., Szilvássy, Z., Juhász, B., Gesztelyi, R.: A Body of Circumstantial Evidence for the Irreversible Ectonucleotidase Inhibitory Action of FSCPX, an Agent Known as a Selective Irreversible A1 Adenosine Receptor Antagonist So Far.
Int. J. Mol. Sci. 22 (18), 1-21, 2021.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
14.
Wachal, Z., Szilágyi, A., Takács, B., Szabó, A. M., Priksz, D., Bombicz, M., Szilvássy, J., Juhász, B., Szilvássy, Z., Varga, B.: Improved Survival and Retinal Function of Aging ZDF Rats in Long-Term, Uncontrolled Diabetes by BGP-15 Treatment.
Front. Pharmacol. 12, 1-11, 2021.
Journal metrics:
Q1 Pharmacology
Q1 Pharmacology (medical)
DEENK University of Debrecen
© 2012 University of Debrecen